https://www.selleckchem.com/pr....oducts/jnk-inhibitor
002), mastectomy flap necrosis (7% vs 15%, P = 0.02), seroma (1% vs 9%, P 0.001), and wound breakdown (3% vs 9%, P = 0.05). Postoperative complication rates did not significantly differ among enhanced recovery patients discharged same day. Postoperative admissions significantly decreased after enhanced recovery implementation (100% to 48%, P 0.001), and admitted enhanced recovery patients experienced a lower length of stay (1.2 vs 1.8, P 0.001). Enhanced recovery patients experienced a lower incidence of ≥1 unp
Like
Comment
Share
